Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
2006-04-04
2006-04-04
Fay, Zohreh (Department: 1618)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
active
07022688
ABSTRACT:
This invention provides a method of using 17β-dihydroequilenin or a pharmaceutically acceptable salt of 17β-dihydroequilenin-3-sulfate ester as an antioxidant.
REFERENCES:
patent: 4154820 (1979-05-01), Simoons
patent: 0744176 (1996-11-01), None
patent: 0761679 (1997-03-01), None
patent: 9409789 (1994-05-01), None
Bhavnani, B.R. et al., Interaction of ring B unsaturated estrogens with estrogen receptors of human endometrium and rat uterus, Steroids, vol. 56, Apr. 1991, p. 201.
Stern, M.D. et al., Studies on the mechanism of action of conjugated equine oestrogens, Endometrial Cancer, (1978), p. 309.
Stern, M.D., Pharmacology of conjugated oestrogens, Maturitas, (1982) pp. 333-339.
Weisiger, R.A., Oxygen radicals and Ischemic Tissue Injury, Gastroenterology, vol. 90, No. 2, p. 494.
Biemond, P. et al., Superoxide dependent iron release from ferritin in inflammatory diseases, Free Radical Biology and Medicine, vol. 4, (1988) pp. 185-198.
Braughler, J.M. et al., Central nervous system trauma and stroke, Free Radical Biology and Medicine, vol. 6, (1989) pp. 289-301.
Rice-Evans, C.A. et al., Current Status of antioxidant therapy, Free Radical Biology and Medicine, vol. 15 (1993) pp. 77-96.
Del Maestro, R.F., An approach to free radicals in medicine and biology, Acta Physiol. Scand, (1980) Suppl. 492:153-168.
Subbiah, M.T.R. et al., Antioxidant potential of specific estrogens on lipid peroxidation J. Clin. Endocr. Metab., 1993, 77:1095-7.
Wiseman, H., Tamoxifen: new membrane-mediated mechanisms of action and therapeutic advances, TIPS, vol. 15 (Mar. 1994).
Tang, M. et al., Metab Clin Exp, 1996, 45(4), pp. 411-414.
Adelman Steven J.
Prozialeck Dorothy H.
Cozen O'Connor
Fay Zohreh
Milowsky, Esq. Arnold S.
Wyeth
LandOfFree
Use of 17β-dihydroequilenin as an antioxidant does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of 17β-dihydroequilenin as an antioxidant, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of 17β-dihydroequilenin as an antioxidant will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3607352